Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Curelab Oncology

Curelab Oncology?uq=AFYHfsyn
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Operator of a biotechnology company designed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives. The company's anti-cancer biologics offers immune stimulators and oncolytic virus for the treatmenet of cancer patients, enabling them to treat cancer.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Skolkovo
  • Russia

+7 8 (000) 000-00-00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Curelab Oncology’s full profile, request a free trial.

Curelab Oncology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC Completed Startup
1. Grant 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Curelab Oncology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Pharma 2020 Government 000 0000 000000 0
VEB Innovations Not-For-Profit Venture Capital Minority 000 0000 000000 0

Curelab Oncology Executive Team (1)

Name Title Board
Seat
Contact
Info
David Peace General Director